Clustering of longitudinal data by using an extended baseline: A new method for treatment efficacy clustering in longitudinal data

Abstract

Heterogeneity in treatment efficacy is a major concern in clinical trials. Clustering may help to identify the treatment responders and the non-responders. In the context of longitudinal cluster analyses, sample size and variability of the times of measurements are the main issues with the current methods. Here, we propose a new two-step method for the Clustering of Longitudinal data by using an Extended Baseline. The first step relies on a piecewise linear mixed model for repeated measurements with a treatment-time interaction. The second step clusters the random predictions and considers several parametric (model-based) and non-parametric (partitioning, ascendant hierarchical clustering) algorithms. A simulation study compares all options of the clustering of longitudinal data by using an extended baseline method with the latent-class mixed model. The clustering of longitudinal data by using an extended baseline method with the two model-based algorithms was the more robust model. The clustering of longitudinal data by using an extended baseline method with all the non-parametric algorithms failed when there were unequal variances of treatment effect between clusters or when the subgroups had unbalanced sample sizes. The latent-class mixed model failed when the between-patients slope variability is high. Two real data sets on neurodegenerative disease and on obesity illustrate the clustering of longitudinal data by using an extended baseline method and show how clustering may help to identify the marker(s) of the treatment response. The application of the clustering of longitudinal data by using an extended baseline method in exploratory analysis as the first stage before setting up stratified designs can provide a better estimation of treatment effect in future clinical trials.

Keywords

Clustering longitudinal data personalized medicine treatment effect Huntington’s disease obesity

Get full access to this article

View all access options for this article.

References

Everitt

Landau

Leese

et al.

Cluster analysis, 5th ed. Chichester, West Sussex, U.K: Wiley-Blackwell, 2011.

Koestler

Marsit

Christensen

et al.

A recursively partitioned mixture model for clustering time-course gene expression data. Trans Cancer Res 2014; 3: 217–217.

Harrington

Velicer

Ramsey

. Typology of alcohol users based on longitudinal patterns of drinking. Addict Behav 2014; 39: 607–621.

Castellini

Fioravanti

Sauro

et al.

Latent profile and latent transition analyses of eating disorder phenotypes in a clinical sample: a 6-year follow-up study. Psych Res 2013; 207: 92–99.

Kent

Kongsted

. Identifying clinical course patterns in sms data using cluster analysis. Chiropract Manual Therap 2012; 20: 1–12.

Tepper

Randolph

Jr McConnell

et al.

Trajectory clustering of estradiol and follicle-stimulating hormone during the menopausal transition among women in the study of women’s health across the nation (swan). J Clin Endocrinol Metabol 2012; 97: 2872–2880.

Muthén

. Integrating person-centered and variable-centered analyses: growth mixture modeling with latent trajectory classes. Alcoholism: Clin Exp Res 2000; 24: 882–891.

Verbeke

Lesaffre

. A linear mixed-effects model with heterogeneity in the random-effects population. J Am Stat Assoc 1996; 91: 217–221.

Genolini

Falissard

. Kml: k-means for longitudinal data. Comput Stat 2010; 25: 317–328.

10.

Madsen

Miller

Province

. The use of an extended baseline period in the evaluation of treatment in a longitudinal duchenne muscular dystrophy trial. Stat Med 1986; 5: 231–241.

11.

Laird

Ware

. Random-effects models for longitudinal data. Biometrics 1982; 38: 963–974.

12.

Laird

. Missing data in longitudinal studies. Stat Med 1988; 7: 305–315.

13.

Fraley

Raftery

. Model-based clustering, discriminant analysis, and density estimation. J Am Stat Assoc 2002; 97: 611–631.

14.

Redner

Walker

. Mixture densities, maximum likelihood and the em algorithm. SIAM Rev 1984; 26: 195–239.

15.

Banfield

Raftery

. Model-based gaussian and non-gaussian clustering. Biometrics 1993; 49: 803–821.

16.

Hartigan

Wong

. Algorithm as 136: a k-means clustering algorithm. Appl Stat 1979; 28: 100–108.

17.

MacQueen J, et al. Some methods for classification and analysis of multivariate observations. In: Proceedings of the fifth Berkeley symposium on mathematical statistics and probability, Oakland, CA, USA, vol. 1, pp. 281–297.

18.

Kaufman

Rousseeuw

Statistical data analysis based on the Ll norm. In: dodge

(ed). Clustering by means of medoids, Amsterdam: North-Holland, 1987, pp. 405–416.

19.

Day

Edelsbrunner

. Efficient algorithms for agglomerative hierarchical clustering methods. J Class 1984; 1: 7–24.

20.

Team RDC. R: a language and environment for statistical computing. R Foundation for statistical computing, Vienna, Austria, http://www.R-project.org (2013).

21.

Pinheiro J, Bates D, DebRoy S, et al. nlme: linear and nonlinear mixed effects models. R package version 3.1-105. 2012, http://CRAN.R-project.org/package=nlme.

22.

Fraley C, Raftery AE, Murphy TB, et al. mclust: normal mixture modeling for model-based clustering, classification, and density estimation. R package version 4.3. 2012, http://CRAN.R-project.org/package=mclust.

23.

Lucas A. amap: another multidimensional analysis package, http://CRAN.R-project.org/package=amap. R package version 0.8-12 (2014).

24.

Maechler M and Rousseeuw P. cluster: cluster analysis basics and extensions. R package version 1.14.3. 2012, http://CRAN.R-project.org/package=cluster.

25.

Proust-Lima C, Philipps V, Diakite A, et al. lcmm: estimation of extended mixed models using latent classes and latent processes, http://CRAN.R-project.org/package=lcmm. R package version 1.6.6 (2014).

26.

Bates

Harper

Jones

. Huntington’s disease: oxford monographs on medical genetics, New York: Oxford University Press, 2002.

27.

Désaméricq

Dolbeau

Verny

et al.

Effectiveness of anti-psychotics and related drugs in the huntington french-speaking group cohort. PLoS ONE 2014; 9. e85430. DOI:10.1371/journal.pone.0085430.

28.

Trottier

Biancalana

Mandel

. Instability of cag repeats in huntington’s disease: relation to parental transmission and age of onset. J Med Gen 1994; 31: 377–382.

29.

Brandt

Bylsma

Gross

et al.

Trinucleotide repeat length and clinical progression in huntington’s disease. Neurology 1996; 46: 527–531.

30.

Langbehn

Hayden

Paulsen

. Cag-repeat length and the age of onset in huntington disease (hd): a review and validation study of statistical approaches. Am J Med Gen Part B: Neuropsych Gen 2010; 153: 397–408.

31.

Livhits

Mercado

Yermilov

et al.

Preoperative predictors of weight loss following bariatric surgery: systematic review. Obes Surg 2012; 22: 70–89.

32.

Agüera

García-Ruiz-de Gordejuela

Vilarrasa

et al.

Psychological and personality predictors of weight loss and comorbid metabolic changes after bariatric surgery. European Eating Disorders Rev 2015; 23: 509–516.

33.

Strenio

Weisberg

Bryk

. Empirical bayes estimation of individual growth-curve parameters and their relationship to covariates. Biometrics 1983; 39: 71–86.

34.

Proust-Lima

Dartigues

Jacqmin-Gadda

. Misuse of the linear mixed model when evaluating risk factors of cognitive decline. Am J Epidemiol 2011; 174: 1077–1088.

35.

James

Sugar

. Clustering for sparsely sampled functional data. J Am Stat Assoc 2003; 98: 397–408.

36.

Trusheim

Burgess

et al.

Quantifying factors for the success of stratified medicine. Nature Rev Drug Discov 2011; 10: 817–833.